# The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-cost-effective-price-of-lecanemab-for-patients-with-early-alzheimer-s/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xin Xia,Sandar Aye,Oskar Frisell,Emil Aho,Ron Handels,Yunfei Li,Anders Wimo,Bengt Winblad,Maria Eriksdotter,Tobias Skillbäck,Silke Kern,Henrik Zetterberg,Linus Jönsson |
| Citations | 3 |
| DOI | 10.1007/s40273-025-01527-7 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s40273-025-01527-7.pdf |
| OpenAlex ID | https://openalex.org/W4412722895 |
| PMID | 40730714 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Sandar Aye](https://scholariq.org/researchers/sandar-aye/)

## Paper journal

- [PharmacoEconomics](https://scholariq.org/journals/pharmacoeconomics/)

## Paper primary topic

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)

## Paper topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.